Key result
Left ventricular assist devices (LVADs) provide improved survival benefits and meaningful changes in quality of life for patients with Stage D heart failure.
Why the study?
Internists face challenges in identifying patients who need referral for advanced therapies as well as managing patients with left ventricular assist devices.
This review provides internists with essential knowledge regarding the indications, management, and complications of left ventricular assist devices in patients with advanced heart failure.
Left ventricular assist devices (LVADs) have revolutionized therapy for patients with Stage D heart failure (HF) with reduced systolic function providing not only improved survival benefits but also meaningful changes in quality of life and functional capacity. With technological advances and improved durability of devices, length of survival has significantly improved. With continued organ donor shortage, LVADs are frequently serving as a substitute for cardiac transplant as destination therapy, particularly among the elderly. Internists not only face the important challenge of identifying the patients in need referral for these advanced therapies, they are also faced with the challenges of taking care of these patients. This review will help the internists to better understand the present status, indications and advances in LVADs and also understand the complications and adverse effects associated with these devices.
No takes yet. Share an insight, caveat, or question.
Boruah et al. (2019) conducted a review in Stage D heart failure. Left Ventricular Assist Devices (LVADs) vs. Medical therapy or older generation LVADs was evaluated. Left ventricular assist devices (LVADs) provide improved survival benefits and meaningful changes in quality of life for patients with Stage D heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: